39.80
price up icon1.42%   0.46
after-market Handel nachbörslich: 39.80
loading

Finanzdaten der Xenon Pharmaceuticals Inc-Aktie (XENE)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
9.96%
59.04
53.70 55.68 55.62 49.05
Depreciation and Amortization
29.61%
0.599
0.851 1.734 0.602 0.354
Operating Income/Loss
9.96%
-59.04
-53.70 -55.68 -55.62 -49.05
Nonoperating Income/Loss
31.73%
11.52
8.747 7.065 7.943 7.614
Income/Loss From Continuing Operations Before Tax
5.72%
-47.52
-44.95 -48.62 -47.68 -41.44
Income Tax Expense/Benefit, Deferred
301.50%
0.403
-0.20 -0.156 -0.224 0.288
Income Tax Expense/Benefit
300.98%
0.412
-0.205 -0.157 -0.22 0.29
Income/Loss From Continuing Operations After Tax
7.13%
-47.93
-44.74 -48.46 -47.46 -41.73
Net Income/Loss
7.13%
-47.93
-44.74 -48.46 -47.46 -41.73
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7,460%
77.59
1.0263 66.00 65.86 65.72
Diluted Average Shares
7,460%
77.59
1.0263 66.00 65.86 65.72
Basic Earnings Per Share
3.13%
-0.62
-0.64 -0.73 -0.72 -0.63
Diluted Earnings Per Share
3.13%
-0.62
-0.64 -0.73 -0.72 -0.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.56%
$367.36
price up icon 0.77%
$194.56
price up icon 0.07%
$108.23
price up icon 5.98%
Kapitalisierung:     |  Volumen (24h):